Gpr124 is essential for blood–brain barrier integrity in central nervous system disease

Abstract

Although blood–brain barrier (BBB) compromise is central to the etiology of diverse central nervous system (CNS) disorders, endothelial receptor proteins that control BBB function are poorly defined. The endothelial G-protein-coupled receptor (GPCR) Gpr124 has been reported to be required for normal forebrain angiogenesis and BBB function in mouse embryos, but the role of this receptor in adult animals is unknown. Here Gpr124 conditional knockout (CKO) in the endothelia of adult mice did not affect homeostatic BBB integrity, but resulted in BBB disruption and microvascular hemorrhage in mouse models of both ischemic stroke and glioblastoma, accompanied by reduced cerebrovascular canonical Wnt–β-catenin signaling. Constitutive activation of Wnt–β-catenin signaling fully corrected the BBB disruption and hemorrhage defects of Gpr124-CKO mice, with rescue of the endothelial gene tight junction, pericyte coverage and extracellular-matrix deficits. We thus identify Gpr124 as an endothelial GPCR specifically required for endothelial Wnt signaling and BBB integrity under pathological conditions in adult mice. This finding implicates Gpr124 as a potential therapeutic target for human CNS disorders characterized by BBB disruption.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Endothelial Gpr124 deficiency induces rapid BBB breakdown and hemorrhagic transformation following brain ischemia and reperfusion.
Figure 2: Activation of endothelial Wnt–β-catenin signaling rescues the hemorrhagic-stroke phenotype of Gpr124-deficient mice.
Figure 3: Gpr124–Wnt signaling regulates endothelial tight junction, pericyte and extracellular matrix following stroke.
Figure 4: Endothelial Gpr124 deficiency increases tumor hemorrhage and reduces survival in experimental glioblastoma.
Figure 5: Endothelial activation of Wnt–β-catenin signaling reduces tumor hemorrhage and edema in endothelial-specific Gpr124-deleted mice with glioblastoma.
Figure 6: Gpr124–Wnt signaling increases BBB integrity in glioblastoma by regulating tight-junction protein, pericyte coverage, Glut1 and the ECM.

Accession codes

Primary accessions

Gene Expression Omnibus

References

  1. 1

    Obermeier, B., Daneman, R. & Ransohoff, R.M. Development, maintenance and disruption of the blood-brain barrier. Nat. Med. 19, 1584–1596 (2013).

  2. 2

    Engelhardt, B. & Liebner, S. Novel insights into the development and maintenance of the blood-brain barrier. Cell Tissue Res. 355, 687–699 (2014).

  3. 3

    Dejana, E. & Nyqvist, D. News from the brain: the GPR124 orphan receptor directs brain-specific angiogenesis. Sci. Transl. Med. 2, 58ps53 (2010).

  4. 4

    McCarty, J.H. et al. Selective ablation of alphav integrins in the central nervous system leads to cerebral hemorrhage, seizures, axonal degeneration and premature death. Development 132, 165–176 (2005).

  5. 5

    Proctor, J.M., Zang, K., Wang, D., Wang, R. & Reichardt, L.F. Vascular development of the brain requires beta8 integrin expression in the neuroepithelium. J. Neurosci. 25, 9940–9948 (2005).

  6. 6

    Ben-Zvi, A. et al. Mfsd2a is critical for the formation and function of the blood-brain barrier. Nature 509, 507–511 (2014).

  7. 7

    Vallon, M., Chang, J., Zhang, H. & Kuo, C.J. Developmental and pathological angiogenesis in the central nervous system. Cell. Mol. Life Sci. 71, 3489–3506 (2014).

  8. 8

    Stenman, J.M. et al. Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science 322, 1247–1250 (2008).

  9. 9

    Daneman, R. et al. Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc. Natl. Acad. Sci. USA 106, 641–646 (2009).

  10. 10

    Xu, Q. et al. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 116, 883–895 (2004).

  11. 11

    Ye, X. et al. Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell 139, 285–298 (2009).

  12. 12

    Wang, Y. et al. Norrin/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity. Cell 151, 1332–1344 (2012).

  13. 13

    Paes, K.T. et al. Frizzled 4 is required for retinal angiogenesis and maintenance of the blood-retina barrier. Invest. Ophthalmol. Vis. Sci. 52, 6452–6461 (2011).

  14. 14

    Zhou, Y. et al. Canonical WNT signaling components in vascular development and barrier formation. J. Clin. Invest. 124, 3825–3846 (2014).

  15. 15

    Junge, H.J. et al. TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/β-catenin signaling. Cell 139, 299–311 (2009).

  16. 16

    Kuhnert, F. et al. Essential regulation of CNS angiogenesis by the orphan G protein-coupled receptor GPR124. Science 330, 985–989 (2010).

  17. 17

    Cullen, M. et al. GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier. Proc. Natl. Acad. Sci. USA 108, 5759–5764 (2011).

  18. 18

    Anderson, K.D. et al. Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor. Proc. Natl. Acad. Sci. USA 108, 2807–2812 (2011).

  19. 19

    Chandana, E.P. et al. Involvement of the Reck tumor suppressor protein in maternal and embryonic vascular remodeling in mice. BMC Dev. Biol. 10, 84 (2010).

  20. 20

    Vanhollebeke, B. et al. Tip cell-specific requirement for an atypical Gpr124- and Reck-dependent Wnt/β-catenin pathway during brain angiogenesis. eLife 4, e06489 (2015).

  21. 21

    Liebner, S. et al. Wnt/β-catenin signaling controls development of the blood-brain barrier. J. Cell Biol. 183, 409–417 (2008).

  22. 22

    Lippmann, E.S. et al. Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. Nat. Biotechnol. 30, 783–791 (2012).

  23. 23

    Paolinelli, R. et al. Wnt activation of immortalized brain endothelial cells as a tool for generating a standardized model of the blood brain barrier in vitro. PLoS One 8, e70233 (2013).

  24. 24

    Tran, K.A. et al. Endothelial β-catenin signaling is required for maintaining adult blood-brain barrier integrity and central nervous system homeostasis. Circulation 133, 177–186 (2016).

  25. 25

    Wang, W. et al. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats. Mol. Neurobiol. 53, 7028–7036 (2016).

  26. 26

    Wu, C. et al. Wnt/β-catenin coupled with HIF-1α/VEGF signaling pathways involved in galangin neurovascular unit protection from focal cerebral ischemia. Sci. Rep. 5, 16151 (2015).

  27. 27

    Reis, M. et al. Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression. J. Exp. Med. 209, 1611–1627 (2012).

  28. 28

    Zhou, Y. & Nathans, J. Gpr124 controls CNS angiogenesis and blood-brain barrier integrity by promoting ligand-specific canonical wnt signaling. Dev. Cell 31, 248–256 (2014).

  29. 29

    Posokhova, E. et al. GPR124 functions as a WNT7-specific coactivator of canonical β-catenin signaling. Cell Reports 10, 123–130 (2015).

  30. 30

    Maier, C.M., Hsieh, L., Crandall, T., Narasimhan, P. & Chan, P.H. Evaluating therapeutic targets for reperfusion-related brain hemorrhage. Ann. Neurol. 59, 929–938 (2006).

  31. 31

    McCullough, L. et al. Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J. Neurosci. 24, 257–268 (2004).

  32. 32

    Wang, Y. et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465, 483–486 (2010).

  33. 33

    Xiong, X. et al. IL-4 is required for sex differences in vulnerability to focal ischemia in mice. Stroke 46, 2271–2276 (2015).

  34. 34

    Ritzel, R.M., Capozzi, L.A. & McCullough, L.D. Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke. Horm. Behav. 63, 238–253 (2013).

  35. 35

    Daneman, R. et al. The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS One 5, e13741 (2010).

  36. 36

    Moro, E. et al. In vivo Wnt signaling tracing through a transgenic biosensor fish reveals novel activity domains. Dev. Biol. 366, 327–340 (2012).

  37. 37

    Harada, N. et al. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J. 18, 5931–5942 (1999).

  38. 38

    Huang, W., Sherman, B.T. & Lempicki, R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 (2009).

  39. 39

    Lindahl, P., Johansson, B.R., Levéen, P. & Betsholtz, C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277, 242–245 (1997).

  40. 40

    Lindblom, P. et al. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev. 17, 1835–1840 (2003).

  41. 41

    Armulik, A. et al. Pericytes regulate the blood-brain barrier. Nature 468, 557–561 (2010).

  42. 42

    Bell, R.D. et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68, 409–427 (2010).

  43. 43

    Daneman, R., Zhou, L., Kebede, A.A. & Barres, B.A. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468, 562–566 (2010).

  44. 44

    Armulik, A., Genové, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 21, 193–215 (2011).

  45. 45

    Hall, C.N. et al. Capillary pericytes regulate cerebral blood flow in health and disease. Nature 508, 55–60 (2014).

  46. 46

    Shen, J. et al. PDGFR-β as a positive regulator of tissue repair in a mouse model of focal cerebral ischemia. J. Cereb. Blood Flow Metab. 32, 353–367 (2012).

  47. 47

    Hayashi, T., Noshita, N., Sugawara, T. & Chan, P.H. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J. Cereb. Blood Flow Metab. 23, 166–180 (2003).

  48. 48

    Carmeliet, P. & Jain, R.K. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat. Rev. Drug Discov. 10, 417–427 (2011).

  49. 49

    Bürgi, S. et al. In vivo imaging of hypoxia-inducible factor regulation in a subcutaneous and orthotopic GL261 glioma tumor model using a reporter gene assay. Mol. Imaging http://dx.doi.org/10.2310/7290.2014.00029 (2014).

  50. 50

    Airley, R. et al. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin. Cancer Res. 7, 928–934 (2001).

  51. 51

    Ulrich, F. et al. Reck enables cerebrovascular development by promoting canonical Wnt signaling. Development 143, 1055 (2016).

  52. 52

    Wang, H. et al. The Reck tumor suppressor protein alleviates tissue damage and promotes functional recovery after transient cerebral ischemia in mice. J. Neurochem. 115, 385–398 (2010).

  53. 53

    Luhmann, U.F. et al. Vascular changes in the cerebellum of Norrin /Ndph knockout mice correlate with high expression of Norrin and Frizzled-4. Eur. J. Neurosci. 27, 2619–2628 (2008).

  54. 54

    Ye, X., Smallwood, P. & Nathans, J. Expression of the Norrie disease gene (Ndp) in developing and adult mouse eye, ear, and brain. Gene Expr. Patterns 11, 151–155 (2011).

  55. 55

    Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929–11947 (2014).

  56. 56

    Nitta, T. et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 161, 653–660 (2003).

  57. 57

    Chen, Z.L. et al. Ablation of astrocytic laminin impairs vascular smooth muscle cell function and leads to hemorrhagic stroke. J. Cell Biol. 202, 381–395 (2013).

  58. 58

    Gould, D.B. et al. Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science 308, 1167–1171 (2005).

  59. 59

    Winkler, E.A., Bell, R.D. & Zlokovic, B.V. Central nervous system pericytes in health and disease. Nat. Neurosci. 14, 1398–1405 (2011).

  60. 60

    Winkler, E.A. et al. GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration. Nat. Neurosci. 18, 521–530 (2015).

  61. 61

    Ventura, A. et al. Restoration of p53 function leads to tumour regression in vivo. Nature 445, 661–665 (2007).

  62. 62

    Maretto, S. et al. Mapping Wnt/β-catenin signaling during mouse development and in colorectal tumors. Proc. Natl. Acad. Sci. USA 100, 3299–3304 (2003).

  63. 63

    Kuo, C.J. et al. Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Proc. Natl. Acad. Sci. USA 98, 4605–4610 (2001).

  64. 64

    Beck, A.H. et al. 3′-end sequencing for expression quantification (3SEQ) from archival tumor samples. PLoS One 5, e8768 (2010).

Download references

Acknowledgements

We are grateful to members of the Kuo laboratory, J. Yang and P. Han for helpful comments. We thank P. Chu (Stanford Histology Core Facility), J. Perrino (Stanford Electron Microscopy Facility) and C. Crumpton, T. Knaak, B. Gomez, O. Herman and M. Bigos (Stanford Shared FACS Facility). FACS sorting and analysis used instruments in the Shared FACS Facility, obtained using NIH S10 Shared Instrument Grant (S10RR025518-01, S10RR027431-01) to the Stanford Shared FACS Facility. We thank M. Edwards (Department of Neurosurgery, Stanford University) for providing the human glioblastoma specimens. We thank R. Adams (Max Planck Institute for Molecular Biomedicine) for providing the Cdh5-CreER mice. We thank the National Cancer Institute–DCTD Repository for providing the GL261 cell line. J.C. was supported by an American Heart Association Postdoctoral Fellowship (15POST23020039) and M.R.M. was supported by the Stanford Medical Scientist Training Program (NIGMS GM07365). J.H.Z. was supported by a Howard Hughes Medical Institute Medical Research Fellows Program grant. H.Y.C. was supported by NIH grant P50-HG007735. This work was also supported by American Heart Association Innovative Science Award 12PILT12850014, a Stanford Stroke Collaborative Action Network Pilot Grant and NIH grants R01HL074267, R01NS064517, U01DK085527 and R01CA158528 to C.J.K.

Author information

J.C. and M.R.M. designed and performed experiments, analyzed the data and wrote the manuscript. C.M., X.L., K. Y., L.X., L.L. and J.W. performed the tMCAO and tumor cell implantation surgeries, performed experiments and analyzed data. J.W.K, V.R., M.V., C.K., J.H.Z., A.T.M., S.G., T.R., R.L., F.K., X.H., J.Y., S.-H.C., A.D.B., L.D. and D.C.C. performed experiments and analyzed data. L.Y. and X.W. analyzed the RNA-seq data. S.H.C., L.D.S., M.S., P.C., H.Y.C., R.G.G. and K.A. designed experiments and analyzed the data. C.J.K. conceived and supervised the project, designed experiments, interpreted the data and wrote the manuscript.

Correspondence to Calvin J Kuo.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Figures and Tables

Supplementary Figures 1–16 and Supplementary Tables 1–3 (PDF 10947 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Further reading